Mutations of the core gene sequence of HCV from patients with hepatocellular carcinoma in China and Japan

中国和日本肝癌患者HCV核心基因序列突变

基本信息

  • 批准号:
    11695087
  • 负责人:
  • 金额:
    $ 1.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Firstly, we investigated the association between hepatocellular carcinoma(HCC)and the genomic characteristics of the hepatitis C virus(HCV)isolated from residents of the inshore region of the Yangtze River. That area of China has one of the highest incidences of HCC.Our data revealed that nucleotide substitutions are unevenly scattered along the HCV genome, with a cluster of missense mutations in the region encoding the second hydrophilic domain of the core protein, and that the number of these mutations in the clustering variable region(CVR)is significantly higher in isolates from HCC patients than in those from individuals with chronic hepatitis. Secondly, we determined the sequence divergence of the CVR in HCV isolates from cancerous and noncancerous liver tissues in Japanese patients with HCC.The number of nucleotide substitutions giving rise to changes in amino acid residues in the CVR was significantly greater in liver tissues than in sera from HCC patients. The number of amino acid residues in the CVR that differed from the representative clone from cancerous liver portions was significantly higher than the number differing from noncancerous portions in each patient. An amino acid alteration from Gly to Ser at core codon 45 in the CVR was dominant in noncancerous portions rather than in cancerous portions and sera from HCC patients. These findings suggest that a large number of mutations, including biologically important amino acid sequence changes in the HCV core gene from liver tissue, might be related to hepatocarcinogenesis.
首先,我们研究了从长江沿岸地区居民分离的丙型肝炎病毒(HCV)基因组特征与肝细胞癌(HCC)之间的关系。中国的该地区是 HCC 发病率最高的地区之一。我们的数据显示,核苷酸取代在 HCV 基因组中分布不均匀,在编码核心蛋白第二亲水结构域的区域存在一簇错义突变,并且来自 HCC 患者的分离株中的聚集可变区 (CVR) 中的这些突变数量明显高于来自慢性肝炎个体的分离株。其次,我们确定了日本 HCC 患者癌性和非癌性肝组织中 HCV 分离株的 CVR 序列差异。导致 CVR 氨基酸残基变化的核苷酸取代数量在肝组织中显着高于 HCC 患者血清。 CVR 中与癌性肝脏部分的代表性克隆不同的氨基酸残基数量显着高于每位患者与非癌性部分的差异数量。 CVR 中核心密码子 45 处从 Gly 到 Ser 的氨基酸变化在非癌性部分中占主导地位,而不是在癌性部分和来自 HCC 患者的血清中占主导地位。这些发现表明,大量突变,包括肝组织中 HCV 核心基因中生物学上重要的氨基酸序列变化,可能与肝癌发生有关。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HorieT,et al.: "Mutations of the core gene sequence of hepatitis C virus isolated from liver tissues with hepatocellular carcinoma"Hepatology Research. 13. 240-251 (1999)
HorieT等人:“从肝细胞癌肝组织中分离出的丙型肝炎病毒核心基因序列的突变”肝病学研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
OmoyaT,et al.: 3rd International Conference on Therapies for Viral Hepatitis(Proceeding). (1999)
OmoyaT 等人:第三届国际病毒性肝炎治疗会议(论文集)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITO Susumu其他文献

ITO Susumu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITO Susumu', 18)}}的其他基金

A Nationwide Survey of Nursery Schooling and Parental Employment in Children with Epilepsy or Febrile Seizures
全国范围内癫痫或热性惊厥儿童的幼儿园教育和家长就业调查
  • 批准号:
    20K02683
  • 财政年份:
    2020
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel diagnosis method for minutecancer by infrared fluorescence endoscopy using fluorescence-emitting antibody by infrared ray excitation.
开发利用红外线激发的荧光发射抗体的红外荧光内窥镜诊断微小癌症的新方法。
  • 批准号:
    08457168
  • 财政年份:
    1996
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Virological features of hepatitis C virus infection in patients with liver diseases in a high risk region for hepatocellular carcinoma in China
我国肝细胞癌高发地区肝病患者丙型肝炎病毒感染的病毒学特征
  • 批准号:
    05670480
  • 财政年份:
    1993
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
EXPERIMENTAL-THEORETICAL STUDY OF COGNITIVE AND SOCIAL FACTERS IN THE QUESTION GENERATION
问题生成中认知和社会因素的实验理论研究
  • 批准号:
    04610035
  • 财政年份:
    1992
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Re-investigate of the mogage system
重新研究莫加吉系统
  • 批准号:
    61301062
  • 财政年份:
    1986
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Co-operative Research (A)

相似海外基金

The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
  • 批准号:
    487828
  • 财政年份:
    2023
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
  • 批准号:
    478700
  • 财政年份:
    2023
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
  • 批准号:
    469805
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10449670
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
  • 批准号:
    10709130
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
  • 批准号:
    460792
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
  • 批准号:
    10683045
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
  • 批准号:
    10620846
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
  • 批准号:
    10597168
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
The effect of opioids, stimulants, and the simultaneous use of both on the hepatitis C virus (HCV) cascade of care in rural communities in the United States
阿片类药物、兴奋剂以及同时使用两者对美国农村社区丙型肝炎病毒 (HCV) 级联护理的影响
  • 批准号:
    10459753
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了